These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1170 related articles for article (PubMed ID: 34200820)

  • 1. Metabolic Reprogramming of Colorectal Cancer Cells and the Microenvironment: Implication for Therapy.
    Nenkov M; Ma Y; Gaßler N; Chen Y
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34200820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential role of the intratumoral microbiota in colorectal cancer immunotherapy.
    Fan S; Zhang W; Zhou L; Wang D; Tang D
    Int Immunopharmacol; 2024 Aug; 137():112537. PubMed ID: 38909493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune System, Microbiota, and Microbial Metabolites: The Unresolved Triad in Colorectal Cancer Microenvironment.
    Hanus M; Parada-Venegas D; Landskron G; Wielandt AM; Hurtado C; Alvarez K; Hermoso MA; López-Köstner F; De la Fuente M
    Front Immunol; 2021; 12():612826. PubMed ID: 33841394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut Microbiota Manipulation as a Tool for Colorectal Cancer Management: Recent Advances in Its Use for Therapeutic Purposes.
    Perillo F; Amoroso C; Strati F; Giuffrè MR; Díaz-Basabe A; Lattanzi G; Facciotti F
    Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32751239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Macrophages-Microbiota Interplay in Colorectal Cancer (CRC)-Related Inflammation: Prognostic and Therapeutic Significance.
    Mola S; Pandolfo C; Sica A; Porta C
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32962159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ANKRD22, a novel tumor microenvironment-induced mitochondrial protein promotes metabolic reprogramming of colorectal cancer cells.
    Pan T; Liu J; Xu S; Yu Q; Wang H; Sun H; Wu J; Zhu Y; Zhou J; Zhu Y
    Theranostics; 2020; 10(2):516-536. PubMed ID: 31903135
    [No Abstract]   [Full Text] [Related]  

  • 7. The Therapeutic Potential of Tackling Tumor-Induced Dendritic Cell Dysfunction in Colorectal Cancer.
    Subtil B; Cambi A; Tauriello DVF; de Vries IJM
    Front Immunol; 2021; 12():724883. PubMed ID: 34691029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crosstalk between gut microbiota and metastasis in colorectal cancer: implication of neutrophil extracellular traps.
    Wu J; Dong W; Pan Y; Wang J; Wu M; Yu Y
    Front Immunol; 2023; 14():1296783. PubMed ID: 37936694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic pathways regulating colorectal cancer initiation and progression.
    La Vecchia S; Sebastián C
    Semin Cell Dev Biol; 2020 Feb; 98():63-70. PubMed ID: 31129171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Crosstalk Between Signaling Pathways and Cancer Metabolism in Colorectal Cancer.
    Hon KW; Zainal Abidin SA; Othman I; Naidu R
    Front Pharmacol; 2021; 12():768861. PubMed ID: 34887764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of SCFAs in gut microbiome and glycolysis for colorectal cancer therapy.
    Wang G; Yu Y; Wang YZ; Wang JJ; Guan R; Sun Y; Shi F; Gao J; Fu XL
    J Cell Physiol; 2019 Aug; 234(10):17023-17049. PubMed ID: 30888065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colorectal Cancer and Metabolism.
    Brown RE; Short SP; Williams CS
    Curr Colorectal Cancer Rep; 2018 Dec; 14(6):226-241. PubMed ID: 31406492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The tumor microenvironment of colorectal cancer metastases: opportunities in cancer immunotherapy.
    Kamal Y; Schmit SL; Frost HR; Amos CI
    Immunotherapy; 2020 Oct; 12(14):1083-1100. PubMed ID: 32787587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-Associated Macrophages (TAMs) in Colorectal Cancer (CRC): From Mechanism to Therapy and Prognosis.
    Wang H; Tian T; Zhang J
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of Gut Microbiota in the Development and Treatment of Colorectal Cancer.
    Lin C; Cai X; Zhang J; Wang W; Sheng Q; Hua H; Zhou X
    Digestion; 2019; 100(1):72-78. PubMed ID: 30332668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between Metabolic Reprogramming and Immune Regulation in Digestive Tract Tumors.
    Liu J; Wang T; Zhang W; Huang Y; Wang X; Li Q
    Oncol Res Treat; 2024; 47(6):273-286. PubMed ID: 38636467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colorectal cancer: Metabolic interactions reshape the tumor microenvironment.
    Chen J; Zhu H; Yin Y; Jia S; Luo X
    Biochim Biophys Acta Rev Cancer; 2022 Sep; 1877(5):188797. PubMed ID: 36100193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of the Tumor Microenvironment by Microbiota-Derived Short-Chain Fatty Acids: Impact in Colorectal Cancer Therapy.
    Gomes S; Rodrigues AC; Pazienza V; Preto A
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut microbiota-stimulated cathepsin K secretion mediates TLR4-dependent M2 macrophage polarization and promotes tumor metastasis in colorectal cancer.
    Li R; Zhou R; Wang H; Li W; Pan M; Yao X; Zhan W; Yang S; Xu L; Ding Y; Zhao L
    Cell Death Differ; 2019 Nov; 26(11):2447-2463. PubMed ID: 30850734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microbe-based management for colorectal cancer.
    Gao ZY; Cui Z; Yan YQ; Ning LJ; Wang ZH; Hong J
    Chin Med J (Engl); 2021 Dec; 134(24):2922-2930. PubMed ID: 34855639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 59.